Clinical Trial Update: Trial of Aggressive Hydration Versus Rectal Indomethacin for Prevention of Post-ERCP Pancreatitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing aggressive hydration to rectal indomethacin for prevention of post-ERCP pancreatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ercp Pancreatitis

Drugs mentioned

• Rectal Indomethacin (indomethacin)
• aggressive hydration

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Post-ERCP Acute Pancreatitis | Phase 2, Phase 3 | Status: COMPLETED